- Location
percutaneous coronary intervention
"-
The Company Believes The Ability to Prevent Such Leakage Is a Key Advantage for Product
Jan 9, 2014Direct Flow Medical (Santa Rosa, CA) has obtained the CE Mark for its 29-mm transcatheter aortic valve replacement device, which it hails as the first fully repositionable percutaneous heart valve. The ability to reposition the Direct Flow ...
-
Miracor Medical Systems Announced 30 Patients Have Been Treated with PICSO System
Nov 14, 2013Austria-based Miracor Medical Systems has announced that 30 patients have been successfully treated with no device-related adverse events using its PICSO (pressure-controlled intermittent coronary sinus occlusion) system designed to improve ...
Tags: PICSO System, Medical Systems
-
Second-Generation Sso2 Therapy IDE Study Results Were Presented by TherOx
Nov 6, 2013TherOx, a medical device company, has presented results from the investigational device exemption (IDE) pilot study on its second-generation supersaturated oxygen (SSO2) therapy system at the 25th annual Transcatheter Cardiovascular ...
Tags: TherOx, medical device
-
Patient Enrollment Is Completed by Therox in IDE Pilot Study for Ami
Sep 13, 2013US-based medical device company TherOx has successfully completed the patient enrollment in its multicenter investigational device exemption (IDE) pilot study to evaluate the second generation system that delivers supersaturated oxygen ...
-
Boston Scientific Introduced IVUS in US, Europe and Japan
Jul 25, 2013US-based medical device manufacturer Boston Scientific has introduced its next generation intravascular ultrasound (IVUS) catheter, called OptiCross, in the US, Europe and Japan following regulatory approvals. OptiCross is designed to be ...
Tags: Boston Scientific, Medicine
-
Boston Scientific Secured 510(K) Approval From The US FDA and CE Mark
Jul 16, 2013Boston Scientific's Guidezilla Guide Extension Catheter has secured 510(k) approval from the US Food and Drug Administration (FDA) and CE Mark, which would enable the company to market the device in the US and European markets. The ...
-
Daiichi Sankyo Company Is Seeking Approval
Jun 20, 2013Daiichi Sankyo Company is seeking approval for an oral antiplatelet agent prasugrel hydrochloride to treat ischemic heart diseased patients undergoing percutaneous coronary intervention (PCI) in Japan. The company has submitted a new drug ...
Tags: Daiichi Sankyo, Medicine
-
St. Jude Medical Has Received CE Mark Approval for Ilumien Optis to Treat CAD
May 20, 2013St. Jude Medical has received CE Mark approval for its Ilumien Optis Percutaneous Coronary Intervention (PCI) Optimization System. PCI, also known as coronary angioplasty, is a non-surgical procedure designed to provide disease assessment ...
Tags: St.Jude Medical, Medical
-
IDE Study of New Sso2 Therapy Device Is Started by Therox
Feb 13, 2013TherOx has started an investigational device exemption (IDE) pilot study of its new supersaturated oxygen (SSO2) therapy device, designed to salvage damaged cardiac muscle in patients with acute myocardial infarction (AMI). The TherOx ...
Tags: TherOx, therapy device, Medical
-
First Patient Enrollment in Therapeutic Hypothermia Device Trial Is Completed by Velomedix
Feb 4, 2013Velomedix has completed enrollment of the first patient in Velocity clinical study of its rapid therapeutic hypothermia system for treating acute myocardial infarction (AMIs or heart attacks). Using a peritoneal-based approach, the ...
Tags: Velomedix, Velocity clinical study, rapid therapeutic hypothermia system
-
The Emergency Room Door Can Makes You Hospital Readmissions
Jan 25, 2013If you recently checked out of a hospital there's a good chance you'll be heading back soon, quite possibly through the emergency room door. Nearly 10 of every 100 hospital patients enter the emergency room within 30 days of their ...
Tags: emergency room, healthcare, hospital
-
Many of Those People Continue to Be Treated by Angioplasty
Jan 11, 2013For almost two decades research has suggested that people with diabetes and multiple clogged arteries live longer and have fewer heart attacks if they undergo bypass surgery instead of angioplasty. Yet many of those people continue to be ...
Tags: diabetes, multiple clogged arteries, healthcare, heart attacks
-
Global Medical Device Company St Jude Medical Has Recruited The First Patient in Its Study
Dec 25, 2012Global medical device company St Jude Medical has enrolled the first patient in its ILUMIEN I observational clinical study. The objective of the study is to determine that an intravascular imaging technology, Optical Coherence Tomography ...
-
Miracor Treats First Three STEMI Patients Using PICSO System For 90 Minutes
Dec 17, 2012Miracor Medical Systems has treated first three ST segment elevation myocardial infarction (STEMI) patients, enrolled in the Prepare Ramses study, using its pressure-controlled intermittent coronary sinus occlusion (PICSO) impulse system ...
-
Arterial Reports Positive Results of Biodegradable Stent From First-in-Human ARTDIVA Study
Dec 17, 2012Arterial Remodeling Technologies has reported positive results of its biodegradable stent from first-in-human Arterial Remodeling Transient DIsmantling Vascular Angioplasty (ARTDIVA) study. The bioresorbable stent, which promotes ...
Tags: clinical trial, clinical technology, clinical research
